BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11135086)

  • 1. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Yango A; Shemin D; Hsu N; Jacques PF; Dworkin L; Selhub J; Bostom AG
    Kidney Int; 2001 Jan; 59(1):324-7. PubMed ID: 11135086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
    Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Jacques PF; Dworkin L; Selhub J
    Transplantation; 2000 May; 69(10):2128-31. PubMed ID: 10852611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
    Ghandour H; Bagley PJ; Shemin D; Hsu N; Jacques PF; Dworkin L; Bostom AG; Selhub J
    Kidney Int; 2002 Dec; 62(6):2246-9. PubMed ID: 12427152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients.
    Hauser AC; Hagen W; Rehak PH; Buchmayer H; Födinger M; Papagiannopoulos M; Bieglmayer C; Apsner R; Köller E; Ignatescu M; Hörl WH; Sunder-Plassmann G
    Am J Kidney Dis; 2001 Apr; 37(4):758-65. PubMed ID: 11273876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients.
    Chiu YW; Chang JM; Hwang SJ; Tsai JC; Chen HC
    Ren Fail; 2009; 31(4):278-83. PubMed ID: 19462276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neither folic nor folinic acid normalize homocysteine levels in hemodialysis patients.
    Armada E; Pérez C; Otero A; Esteban J; Camba M; Gayoso P; Suárez D
    Clin Nephrol; 2003 Sep; 60(3):168-75. PubMed ID: 14524579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients.
    Trimarchi H; Schiel A; Freixas E; Díaz M
    Nephron; 2002 May; 91(1):58-63. PubMed ID: 12021520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients.
    Sombolos K; Papaioannou A; Christidou F; Natse T; Bamichas G; Gionanlis L; Katsaris G; Progia E
    Int Urol Nephrol; 2006; 38(3-4):725-30. PubMed ID: 17115295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.
    Touam M; Zingraff J; Jungers P; Chadefaux-Vekemans B; Drüeke T; Massy ZA
    Kidney Int; 1999 Dec; 56(6):2292-6. PubMed ID: 10594808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.